SUVN-F90101

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameSUVN-F90101
Drug Alias NameSUVN-F90101SUVN-F91201
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCannabinoid CB2 receptor agonistsNicotinic acetylcholine receptor alpha-4/beta-2 agonists
TargetsCannabinoid CB2 receptorNicotinic acetylcholine receptor alpha-4/beta-2
Therapy Area/IndicationsMetabolic DiseasesAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSuven Life Sciences Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSuven Life Sciences Ltd
Active IndicationsN/A
Inactive IndicationsMetabolic DiseasesAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A